Riskpilot← Back to searchSign inGet full accessACTABIO ApS
APSActiveCVR 26025338Kongemarken 11Research and experimental development on natural sciences and engineering · NACE 7210Est. 20012 employeeswww.actabio.dk
Revenue 2024
DKK 0
EBITDA margin
—
-34% vs 2023
Equity ratio
-1025.8%
Financial strength
Net profit 2024
DKK -77K
-34% vs 2023
| Revenue | DKK 0 | — |
| EBITDA | DKK -77K | -34% |
| Net profit | DKK -77K | -34% |
| Total assets | DKK 31K | +41% |
| Equity | DKK -316K | -32% |
| Employees | 2 | — |
Legal name
ACTABIO ApS
CVR number
26025338
Legal form
Anpartsselskab
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
2. maj 2001
Share capital
DKK 125.000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Selskabet tegnes af direktionen.
Company purpose
Selskabets formål er at besidde, købe og sælge værdipapirer, immaterielle rettigheder og materielle produkter af en hver art samt at drive forsknings-, opfindelses-, udviklings-, handels-, forretnings-, forædlings-, landbrugs-, gartneri-, bioteknologi-, medicinal-, helse-, kosmetik-, fødevare-, have-, havearkitekt-, forfatter-, journalist-, kunst-, undervisnings-, censor- og konsulentvirksomhed samt at besidde, tilvejebringe/købe og sælge patenter/intellectual property og beslægtet virksomhed.
Address
Kongemarken 11
Phone
+4553390730
Email
finnokkels@yahoo.dk
Website
www.actabio.dk
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 120 | 154 | 127 | 87 | 22 | 64 | 0 |
| Staff expenses | -0 | -0 | -0 | -0 | -0 | -0 | -50 | -66 | -79 | -58 | -70 | -84 | -28 |
| EBITDA | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | -25 | -30 | -92 | -57 | -77 |
| Depreciation & amort. | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| EBIT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | -25 | -30 | -92 | -57 | -77 |
| Net financials | 0 | 0 | 0 | 0 | 0 | 0 | -0 | -0 | -0 | -0 | -0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | -25 | -30 | -92 | -57 | -77 |
| Tax | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 | -0 |
| Net profit | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -10 | -25 | -30 | -92 | -57 | -77 |
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 1 | 1 | 1 | 1 | 1 | 1 | 23 | 20 | 32 | 8 | 9 | 22 | 31 |
| Equity | -25 | -25 | -25 | -25 | -25 | -25 | -25 | -35 | -60 | -90 | -182 | -240 | -316 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 26 | 26 | 26 | 26 | 26 | 26 | 49 | 56 | 92 | 98 | 192 | 261 | 347 |
| Total debt | 26 | 26 | 26 | 26 | 26 | 26 | 49 | 56 | 92 | 98 | 192 | 261 | 347 |
EBITDA margin
-7684100.0%
This company
15.8%
Market median
-48633644% vs market
20122024
Equity ratio
-1025.8%
This company
38.2%
Market median
-2785% vs market
20122024
Return on equity
-7681400.0%
This company
18.4%
Market median
-41746839% vs market
20122024
Net profit margin
-7681400.0%
This company
8.1%
Market median
-94832199% vs market
20122024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20122024
Debt / equity
1.10×
This company
0.62×
Market median
-77% vs market
20122024
- Annual report 2024Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via CVR / Virk · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via CVR / Virk · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via CVR / Virk · Period 2017-01-01 – 2017-12-31
- Annual report 2016Filed via CVR / Virk · Period 2016-01-01 – 2016-12-31
- Annual report 2015Filed via CVR / Virk · Period 2015-01-01 – 2015-12-31
- Annual report 2014Filed via CVR / Virk · Period 2014-01-01 – 2014-12-31
- Annual report 2013Filed via CVR / Virk · Period 2013-01-01 – 2013-12-31
- Annual report 2012Filed via CVR / Virk · Period 2012-01-01 – 2012-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
TR Audit | Audit | 2001 | — | — |
No data on file.
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Individual | 100.0% | 100.0% | 2008 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of ACTABIO ApS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Tom Rasmussen | Audit | 0 companies |